CADIAN CAPITAL MANAGEMENT, LP - Q3 2017 holdings

$2.14 Billion is the total value of CADIAN CAPITAL MANAGEMENT, LP's 42 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 50.0% .

 Value Shares↓ Weighting
IAC BuyIAC INTERACTIVECORP$197,362,000
+246.2%
1,678,535
+204.0%
9.23%
+232.4%
EFII BuyELECTRONICS FOR IMAGING INC$188,452,000
+56.6%
4,415,465
+73.8%
8.82%
+50.4%
PANW SellPALO ALTO NETWORKS INC$185,073,000
-5.3%
1,284,340
-12.1%
8.66%
-9.1%
JAZZ SellJAZZ PHARMACEUTICALS PLC$172,421,000
-20.4%
1,178,948
-15.3%
8.07%
-23.5%
ZAYO BuyZAYO GROUP HLDGS INC$139,139,000
+69.1%
4,042,395
+51.8%
6.51%
+62.4%
DATA SellTABLEAU SOFTWARE INCcl a$109,339,000
+11.2%
1,460,000
-9.0%
5.12%
+6.8%
ZEN BuyZENDESK INC$90,073,000
+88.2%
3,094,234
+79.6%
4.21%
+80.8%
VRNS SellVARONIS SYS INC$89,416,000
+0.0%
2,134,043
-11.2%
4.18%
-4.0%
RDWR SellRADWARE LTDord$69,236,000
-8.2%
4,106,548
-4.5%
3.24%
-11.8%
YNDX SellYANDEX N V$64,904,000
-13.1%
1,969,782
-30.8%
3.04%
-16.6%
FB SellFACEBOOK INCcl a$63,393,000
-12.3%
371,000
-22.5%
2.97%
-15.7%
PTLA BuyPORTOLA PHARMACEUTICALS INC$63,039,000
+244.2%
1,166,743
+257.8%
2.95%
+230.6%
CMCSA NewCOMCAST CORP NEWcl a$56,527,0001,469,000
+100.0%
2.64%
ZNGA BuyZYNGA INCcl a$54,485,000
+28.1%
14,413,964
+23.4%
2.55%
+23.0%
AMT BuyAMERICAN TOWER CORP NEW$44,542,000
+123.2%
325,885
+116.1%
2.08%
+114.4%
AABA SellALTABA INC$40,406,000
-75.2%
610,000
-79.6%
1.89%
-76.1%
GOOGL BuyALPHABET INCcap stk cl a$39,879,000
+57.7%
40,955
+50.6%
1.87%
+51.5%
GNMK BuyGENMARK DIAGNOSTICS INC$38,833,000
-17.6%
4,032,483
+1.2%
1.82%
-20.9%
ALXN BuyALEXION PHARMACEUTICALS INC$34,371,000
+61.4%
245,000
+40.0%
1.61%
+55.1%
NSTG  NANOSTRING TECHNOLOGIES INC$33,846,000
-2.3%
2,094,4080.0%1.58%
-6.2%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$33,160,000
+1076.7%
192,000
+860.0%
1.55%
+1032.1%
LBRDK SellLIBERTY BROADBAND CORP$32,590,000
-12.8%
341,976
-20.6%
1.52%
-16.3%
TMUS SellT MOBILE US INC$32,020,000
-34.8%
519,298
-35.9%
1.50%
-37.4%
TRVG NewTRIVAGO N V$31,090,0002,865,427
+100.0%
1.46%
TLND SellTALEND S Aads$30,055,000
-11.9%
734,129
-25.2%
1.41%
-15.5%
ETSY SellETSY INC$25,414,000
-62.1%
1,505,567
-66.3%
1.19%
-63.6%
BPMC SellBLUEPRINT MEDICINES CORP$21,874,000
-5.6%
313,965
-31.3%
1.02%
-9.3%
COLL SellCOLLEGIUM PHARMACEUTICAL INC$21,612,000
-23.5%
2,060,284
-8.8%
1.01%
-26.5%
PRO SellPROS HOLDINGS INC$19,065,000
-50.3%
790,084
-43.6%
0.89%
-52.3%
EVH NewEVOLENT HEALTH INCcl a$16,732,000940,000
+100.0%
0.78%
GOOG SellALPHABET INCcap stk cl c$16,449,000
-29.4%
17,150
-33.1%
0.77%
-32.2%
TSRO NewTESARO INC$14,020,000108,600
+100.0%
0.66%
NUVA NewNUVASIVE INC$10,815,000195,000
+100.0%
0.51%
INCY NewINCYTE CORP$10,285,00088,100
+100.0%
0.48%
CMCSA NewCOMCAST CORP NEWcall$9,620,000250,000
+100.0%
0.45%
CUDA BuyBARRACUDA NETWORKS INC$9,001,000
+20.1%
371,492
+14.3%
0.42%
+15.3%
APTI SellAPPTIO INCcl a$7,932,000
-61.4%
429,464
-63.8%
0.37%
-63.0%
SAGE BuySAGE THERAPEUTICS INC$6,701,000
+54.0%
107,561
+96.9%
0.31%
+48.1%
FOLD NewAMICUS THERAPEUTICS INC$6,032,000400,000
+100.0%
0.28%
ABC NewAMERISOURCEBERGEN CORP$3,972,00048,000
+100.0%
0.19%
GWPH NewGW PHARMACEUTICALS PLCads$2,537,00025,000
+100.0%
0.12%
AXGT NewAXOVANT SCIENCES LTD$1,720,000250,000
+100.0%
0.08%
ONCE ExitSPARK THERAPEUTICS INC$0-30,000
-100.0%
-0.09%
W ExitWAYFAIR INCcl a$0-99,800
-100.0%
-0.37%
EEX ExitEMERALD EXPOSITIONS EVENTS I$0-499,900
-100.0%
-0.53%
TWX ExitTIME WARNER INC$0-150,000
-100.0%
-0.73%
FWONK ExitLIBERTY MEDIA CORP DELAWARE$0-455,000
-100.0%
-0.81%
SRPT ExitSAREPTA THERAPEUTICS INC$0-621,458
-100.0%
-1.02%
PYPL ExitPAYPAL HLDGS INC$0-470,697
-100.0%
-1.23%
COMM ExitCOMMSCOPE HLDG CO INC$0-1,220,000
-100.0%
-2.26%
CI ExitCIGNA CORPORATION$0-420,000
-100.0%
-3.42%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
RADWARE LTD34Q3 20214.9%
PALO ALTO NETWORKS INC32Q3 202318.5%
PEGASYSTEMS INC27Q3 20239.1%
ALPHABET INC27Q3 20239.0%
GENMARK DIAGNOSTICS INC27Q1 20202.3%
VARONIS SYS INC26Q3 20239.5%
IAC INTERACTIVECORP24Q2 202017.8%
ELECTRONICS FOR IMAGING INC24Q1 20198.8%
ZOGENIX INC23Q4 20217.1%
NANOSTRING TECHNOLOGIES INC22Q2 20232.5%

View CADIAN CAPITAL MANAGEMENT, LP's complete holdings history.

Latest significant ownerships (13-D/G)
CADIAN CAPITAL MANAGEMENT, LP Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
RADWARE LTDSold outFebruary 14, 202200.0%
TCV Acquisition Corp.February 14, 20222,750,0006.7%
WORLD WRESTLING ENTERTAINMENTINCSold outFebruary 14, 202200.0%
ZOGENIX, INC.February 14, 20224,240,8467.6%
GenMark Diagnostics, Inc.Sold outFebruary 12, 202100.0%
NanoString Technologies IncSold outFebruary 12, 202100.0%
VARONIS SYSTEMS INCFebruary 12, 20211,017,4223.2%
PORTOLA PHARMACEUTICALS INCFebruary 13, 20202,133,3432.7%
ELECTRONICS FOR IMAGING INCFebruary 13, 20193,365,1797.7%
trivago N.V.Sold outFebruary 13, 201900.0%

View CADIAN CAPITAL MANAGEMENT, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View CADIAN CAPITAL MANAGEMENT, LP's complete filings history.

Compare quarters

Export CADIAN CAPITAL MANAGEMENT, LP's holdings